Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Phone: 630-241-4141
Quantumup
Quantumup Sep. 2 at 12:03 PM
Piper Sandler In A Broad Biotech Note Said -- Look for Biotech to Outperform through YE:26 with Multiple Value Driving Events $XBI $IBB $FBT MNTL ARKG LABU Piper Sandler added—Biotech had a strong summer exemplified by Moderna's (MRNA) 177% single day move on positive INTERpath-001 data. We expect Biotech to finish the year strong driven by commercial growth, validating clinical data, unprecedented innovation and continued M&A. We look for growth of Alnylam's (ALNY) AMVUTTRA, Legend's (LEGN) CARVYKTI and Mesoblast's (MESO) Ryoncil. Capricor (CAPR) has a November 22nd PDUFA date for deromicel in DMD, Moderna will present intismeran data, Arrowhead (ARWR) will file the sNDA for REDEMPLO in SHTG and ImmunityBio (IBRX) will report Phase III ANKTIVA data in BCG-naive CIS NMIBC. We look for clinical data readouts from Arvinas (ARVN), CytomX (CTMX), CRISPR (CRSP), Generate Biomedicines (GENB), Monte Rosa (GLUE), Sutro (STRO) and Xencor (XNCR).
0 · Reply
Quantumup
Quantumup Sep. 2 at 11:43 AM
TD Cowen's Biotech Thermometer: $XBI $IBB $FBT MNTL ARKG LABU • Stocks Most/Least Loved By The Buyside • Stocks TD Gets Lots/Few Incoming Calls On • Stocks Where Sentiment Has Improved/Worsened • Milestones That Are Widely Discussed/Debated and That Are Off The Radar Screen 🎯 Potential Acquisition Candidates
0 · Reply
Venge
Venge Aug. 20 at 3:32 AM
$XBI $IBB $ARKG $FBT $LABU Biotecha!!!
0 · Reply
StocktwitsNews
StocktwitsNews May. 13 at 7:34 PM
ONC Stock Gains As BeOne Medicines Wins U.S. Nod For BEQALZI In Rare Lymphoma $ONC $IBB $FBT https://stocktwits.com/news/equity/markets/onc-stock-gains-beone-medicines-wins-us-nod-for-beqalzi-in-rare-lymphoma/cZXLMBuReKY
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Apr. 13 at 2:52 AM
5 Best Health Sector ETFs to Invest in Long Term. Plus 2 honorable mentions. $BBP - Virtus Biotech ETF $FBT - First Trust NYSE® Arca® Biotechnology Index Fund $XBI - State Street® SPDR® S&P® Biotech ETF $PJP - Invesco Pharmaceuticals ETF $IHE - iShares U.S. Pharmaceuticals ETF Honorable mentions: 6. VHT - Vanguard Health Care ETF 7. IHI - iShares U.S. Medical Devices ETF https://x.com/MicahMcDonald8/status/2043521558837354530?s=20
0 · Reply
Billianas
Billianas Apr. 10 at 12:49 PM
$ABVX can drop as quick as it jumped. $XBI $IBB $BBH $FBT
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 25 at 9:17 PM
SRPT Stock Clocks Highest Daily Gain In Nearly 8 Years After Rare Muscle Disorders Study Data But Wall Street's Not Wholly Convinced $SRPT $IJR $FBT https://stocktwits.com/news/equity/markets/srpt-stock-clocks-highest-daily-gain-in-nearly-8-years-after-rare-muscle-disorders-study-data/cZ3pTn6RIjd
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 16 at 7:49 PM
Sarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study $SRPT $IJR $FBT https://stocktwits.com/news/equity/markets/sarepta-shares-rise-as-company-begins-enrollment-in-gene-therapy-safety-enhancement-study/cZ3PezERIQd
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 18 at 5:55 PM
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition $SNSE $XBI $IBB $FBT https://stocktwits.com/news/equity/markets/why-did-snse-stock-surge-today-faeth-buyout/cZR0yVyR4vp
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 17 at 2:00 AM
$FBT Share Price: $207.99 Contract Selected: Aug 21, 2026 $210 Calls Buy Zone: $10.29 – $12.71 Target Zone: $16.49 – $20.15 Potential Upside: 51% ROI Time to Expiration: 185 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Quantumup
Quantumup Sep. 2 at 12:03 PM
Piper Sandler In A Broad Biotech Note Said -- Look for Biotech to Outperform through YE:26 with Multiple Value Driving Events $XBI $IBB $FBT MNTL ARKG LABU Piper Sandler added—Biotech had a strong summer exemplified by Moderna's (MRNA) 177% single day move on positive INTERpath-001 data. We expect Biotech to finish the year strong driven by commercial growth, validating clinical data, unprecedented innovation and continued M&A. We look for growth of Alnylam's (ALNY) AMVUTTRA, Legend's (LEGN) CARVYKTI and Mesoblast's (MESO) Ryoncil. Capricor (CAPR) has a November 22nd PDUFA date for deromicel in DMD, Moderna will present intismeran data, Arrowhead (ARWR) will file the sNDA for REDEMPLO in SHTG and ImmunityBio (IBRX) will report Phase III ANKTIVA data in BCG-naive CIS NMIBC. We look for clinical data readouts from Arvinas (ARVN), CytomX (CTMX), CRISPR (CRSP), Generate Biomedicines (GENB), Monte Rosa (GLUE), Sutro (STRO) and Xencor (XNCR).
0 · Reply
Quantumup
Quantumup Sep. 2 at 11:43 AM
TD Cowen's Biotech Thermometer: $XBI $IBB $FBT MNTL ARKG LABU • Stocks Most/Least Loved By The Buyside • Stocks TD Gets Lots/Few Incoming Calls On • Stocks Where Sentiment Has Improved/Worsened • Milestones That Are Widely Discussed/Debated and That Are Off The Radar Screen 🎯 Potential Acquisition Candidates
0 · Reply
Venge
Venge Aug. 20 at 3:32 AM
$XBI $IBB $ARKG $FBT $LABU Biotecha!!!
0 · Reply
StocktwitsNews
StocktwitsNews May. 13 at 7:34 PM
ONC Stock Gains As BeOne Medicines Wins U.S. Nod For BEQALZI In Rare Lymphoma $ONC $IBB $FBT https://stocktwits.com/news/equity/markets/onc-stock-gains-beone-medicines-wins-us-nod-for-beqalzi-in-rare-lymphoma/cZXLMBuReKY
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Apr. 13 at 2:52 AM
5 Best Health Sector ETFs to Invest in Long Term. Plus 2 honorable mentions. $BBP - Virtus Biotech ETF $FBT - First Trust NYSE® Arca® Biotechnology Index Fund $XBI - State Street® SPDR® S&P® Biotech ETF $PJP - Invesco Pharmaceuticals ETF $IHE - iShares U.S. Pharmaceuticals ETF Honorable mentions: 6. VHT - Vanguard Health Care ETF 7. IHI - iShares U.S. Medical Devices ETF https://x.com/MicahMcDonald8/status/2043521558837354530?s=20
0 · Reply
Billianas
Billianas Apr. 10 at 12:49 PM
$ABVX can drop as quick as it jumped. $XBI $IBB $BBH $FBT
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 25 at 9:17 PM
SRPT Stock Clocks Highest Daily Gain In Nearly 8 Years After Rare Muscle Disorders Study Data But Wall Street's Not Wholly Convinced $SRPT $IJR $FBT https://stocktwits.com/news/equity/markets/srpt-stock-clocks-highest-daily-gain-in-nearly-8-years-after-rare-muscle-disorders-study-data/cZ3pTn6RIjd
0 · Reply
StocktwitsNews
StocktwitsNews Mar. 16 at 7:49 PM
Sarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study $SRPT $IJR $FBT https://stocktwits.com/news/equity/markets/sarepta-shares-rise-as-company-begins-enrollment-in-gene-therapy-safety-enhancement-study/cZ3PezERIQd
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 18 at 5:55 PM
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition $SNSE $XBI $IBB $FBT https://stocktwits.com/news/equity/markets/why-did-snse-stock-surge-today-faeth-buyout/cZR0yVyR4vp
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 17 at 2:00 AM
$FBT Share Price: $207.99 Contract Selected: Aug 21, 2026 $210 Calls Buy Zone: $10.29 – $12.71 Target Zone: $16.49 – $20.15 Potential Upside: 51% ROI Time to Expiration: 185 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 26 at 1:34 PM
Why Did SRPT Stock Rise 6% In Pre-Market Today? $SRPT $IJR $FBT $SAA https://stocktwits.com/news/equity/markets/why-did-srpt-stock-rise-6-in-pre-market-today/cmy7A97R4hd
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 17 at 2:07 AM
$FBT Current Stock Price: $211.36 Contracts to trade: $215 FBT Feb 20 2026 Call Entry: $3.00 Exit: $4.06 ROI: 35% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 12 at 2:05 PM
BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? $BDSX $XLV $VHT $IHI $FBT https://stocktwits.com/news/equity/markets/why-bdsx-stock-surging-premarket-today/cmUaR2sR4E9
0 · Reply
Venge
Venge Nov. 28 at 5:21 PM
$FBT What a sleeper… have a small position.
0 · Reply
macroaxis
macroaxis Apr. 28 at 4:07 PM
$FBT - Volatility alert: First Trust options pin risk is increasing https://www.macroaxis.com/stock-options/FBT/First-Trust-NYSE?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
Eyore
Eyore Feb. 7 at 7:38 AM
$FBT good etf
0 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Jun. 2 at 6:38 AM
5 Best Health Sector ETFs to Own Long-Term $IHI iShares U.S. Medical Devices ETF $RSPH Invesco S&P 500® Equal Weight Health Care ETF $FBT First Trust NYSE Arca Biotechnology Index Fund $VHT Vanguard Health Care Index Fund ETF Shares $XLV Health Care Select Sector SPDR® Fund info
1 · Reply
SemiRetiredBlueCollarGuy
SemiRetiredBlueCollarGuy Jun. 2 at 6:36 AM
5 Best Health Sector ETFs to Own Long-Term $IHI iShares U.S. Medical Devices ETF $RSPH Invesco S&P 500® Equal Weight Health Care ETF $FBT First Trust NYSE Arca Biotechnology Index Fund $VHT Vanguard Health Care Index Fund ETF Shares $XLV Health Care Select Sector SPDR® Fund Chart
0 · Reply